Literature DB >> 11978501

Long-circulating sterically stabilized liposomes as carriers of agents for treatment of infection or for imaging infectious foci.

Irma A J M Bakker-Woudenberg1.   

Abstract

Liposomes are considered as potential carriers for biologically active compounds. One evident drawback of 'classical' liposomes is their fast elimination by cells of the mononuclear phagocyte system (MPS), primarily by liver and spleen. An important breakthrough in this respect is the development of long-circulating liposomes among which liposomes coated with polyethyleneglycol (PEG), the so-called 'sterically stabilized' liposomes (SSL). An important characteristic of SSL is that their prolonged blood residence time and infectious target localization is relatively independent of the lipid dose, particle size or lipid composition of the bilayer. SSL are applied as carriers of antimicrobial agents to achieve infectious target localization, to reduce side effects, or to serve as a micro-reservoir in the circulation. In addition, radiolabelled SSL are used to image infectious and inflammatory foci.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11978501     DOI: 10.1016/s0924-8579(02)00021-3

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  9 in total

1.  PEGylated liposome encapsulation increases the lung tissue concentration of vancomycin.

Authors:  Krishna Muppidi; Jeffrey Wang; Guru Betageri; Andrew S Pumerantz
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

2.  Pharmacokinetics and efficacy of liposomal polymyxin B in a murine pneumonia model.

Authors:  Jie He; Kamilia Abdelraouf; Kimberly R Ledesma; Diana S-L Chow; Vincent H Tam
Journal:  Int J Antimicrob Agents       Date:  2013-08-22       Impact factor: 5.283

3.  Plasma protein distribution and its impact on pharmacokinetics of liposomal amphotericin B in paediatric patients with malignant diseases.

Authors:  Ying Hong; Peter J Shaw; Bruce N Tattam; Christa E Nath; John W Earl; Katherine R Stephen; Andrew J McLachlan
Journal:  Eur J Clin Pharmacol       Date:  2006-12-19       Impact factor: 2.953

4.  Trastuzumab and liposomal Doxorubicin in the treatment of mcf-7 xenograft tumor-bearing mice: combination does not affect drug serum levels.

Authors:  Dawn N Waterhouse; Tetyana Denyssevych; Norma Hudon; Stephen Chia; Karen A Gelmon; Marcel B Bally
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

5.  Formulation and Characterization of Stimuli-Responsive Lecithin-Based Liposome Complexes with Poly(acrylic acid)/Poly(N,N-dimethylaminoethyl methacrylate) and Pluronic® Copolymers for Controlled Drug Delivery.

Authors:  Mónica G Simões; Ayelen Hugo; Andrea Gómez-Zavaglia; Pedro N Simões; Patrícia Alves
Journal:  Pharmaceutics       Date:  2022-03-29       Impact factor: 6.525

6.  Development and stability studies of novel liposomal vancomycin formulations.

Authors:  Krishna Muppidi; Andrew S Pumerantz; Jeffrey Wang; Guru Betageri
Journal:  ISRN Pharm       Date:  2012-01-26

Review 7.  Nanotechnology: intelligent design to treat complex disease.

Authors:  Patrick Couvreur; Christine Vauthier
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.580

Review 8.  Liposome-polymer complex for drug delivery system and vaccine stabilization.

Authors:  Abd Kakhar Umar; Nasrul Wathoni; James H Zothantluanga; Sanjoy Das; Jittima Amie Luckanagul
Journal:  Heliyon       Date:  2022-02-12

Review 9.  Application of poly(ethylene glycol)-distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery.

Authors:  Rongrong Wang; Renzhong Xiao; Zhaowu Zeng; Lili Xu; Junjie Wang
Journal:  Int J Nanomedicine       Date:  2012-08-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.